Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ACP3”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03600350
What this trial is testing

PTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT04090528
What this trial is testing

PTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer

Who this might be right for
Castration-resistant Prostate CancerMetastatic CancerProstate Cancer
University of Wisconsin, Madison 60
Post-approval studies (Phase 4)Study completedNCT00987974
What this trial is testing

Short Term Statin Treatment and Endothelial Dysfunction Due to Ischemia and Reperfusion Injury

Who this might be right for
Ischemia Reperfusion InjuryEndothelial Dysfunction
Radboud University Medical Center 48
Testing effectiveness (Phase 2)Study completedNCT00027599
What this trial is testing

APC8015 and Bevacizumab in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 25
Early research (Phase 1)Study completedNCT00582140
What this trial is testing

Prostatic Acid Phosphatase (PAP) Vaccine in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 22
Early research (Phase 1)Looking for participantsNCT07600554
What this trial is testing

A Phase I Study to Evaluate the Safety and Dosimetry of Imaging With 68Ga-OncoACP3 in Prostate Cancer

Who this might be right for
Prostate Cancer
Philogen S.p.A. 20
Testing effectiveness (Phase 2)Study completedNCT00004658
What this trial is testing

Phase II Study of Ribose, Uridine, and Thymidine for a Complex Syndrome Involving Excessive 5'-Nucleotidase Activity

Who this might be right for
5'-Nucleotidase Syndrome
National Center for Research Resources (NCRR)
Early research (Phase 1)Looking for participantsNCT07090148
What this trial is testing

Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC

Who this might be right for
Prostate Cancer PatientsNon-castrate Prostate CancerRecurrent Prostate Cancer+1 more
University of Wisconsin, Madison 14
Early research (Phase 1)Active Not RecruitingNCT05806814
What this trial is testing

Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
University of Oklahoma 15
Not applicableLooking for participantsNCT07242014
What this trial is testing

68Ga-XACP3 PET/CT in Prostate Cancer

Who this might be right for
Prostate CancerPET/CTACP3
The First Affiliated Hospital of Xiamen University 60
Not applicableLooking for participantsNCT07559201
What this trial is testing

Theranostic Applications of Radionuclides in Prostate Cancer

Who this might be right for
Prostate Cancer (Diagnosis)
Guilin Medical University, China 100
Not applicableStudy completedNCT03361618
What this trial is testing

Effect of Oral Zinc Sulfate Supplementation on Enzymes of Urate Pathway

Who this might be right for
Infertility Unexplained
Babylon University 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07830212
What this trial is testing

Diagnostic Performance of ACP3-Targeted PET Imaging in Patients With Primary and Recurrent Prostate Cancer: An Open-Label, Single-Arm, Single-Center Study

Who this might be right for
Prostatic NeoplasmsProstate Cancer
Yong He 50
Testing effectiveness (Phase 2)Study completedNCT01341652
What this trial is testing

Phase II PAP Plus GM-CSF Versus GM-CSF Alone for Non-metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 99
Testing effectiveness (Phase 2)Study completedNCT00849121
What this trial is testing

Two-Arm Study of a DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) in Patients With Non-Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 17